Regulation of tumour necrosis factor production by mouse peritoneal macrophages: the role of cellular cyclic AMP.

od Katakami, Y, Nakao, Y, Koizumi, T, Katakami, N, Ogawa, R, Fujita, T
Wydane 1988

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised,...

od Saito, H., Yoshizawa, H., Yoshimori, K., Katakami, N., Katsumata, N., Kawahara, M., Eguchi, K.
Wydane 2013

Quantitative Analysis of Conebeam CT for Delineating Stents in Stent-Assisted Coil Embolization

od Kuriyama, T., Sakai, N., Beppu, M., Sakai, C., Imamura, H., Masago, K., Katakami, N., Isoda, H.
Wydane w AJNR Am J Neuroradiol (2018)

Randomised phase III trial of irinotecan combined with cisplatin for advanced non-small-cell lung cancer

od Negoro, S, Masuda, N, Takada, Y, Sugiura, T, Kudoh, S, Katakami, N, Ariyoshi, Y, Ohashi, Y, Niitani, H, Fukuoka, M
Wydane 2003

A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

od Tanioka, M, Kitao, A, Matsumoto, K, Shibata, N, Yamaguchi, S, Fujiwara, K, Minami, H, Katakami, N, Morita, S, Negoro, S
Wydane 2013

Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer

od Katakami, N, Harada, T, Murata, T, Shinozaki, K, Tsutsumi, M, Yokota, T, Arai, M, Tada, Y, Narabayashi, M, Boku, N
Wydane w Ann Oncol (2018)

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group.

od Masuda, N., Fukuoka, M., Fujita, A., Kurita, Y., Tsuchiya, S., Nagao, K., Negoro, S., Nishikawa, H., Katakami, N., Nakagawa, K., Niitani, H.
Wydane 1998

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group tri...

od Kunitoh, H, Tamura, T, Shibata, T, Takeda, K, Katakami, N, Nakagawa, K, Yokoyama, A, Nishiwaki, Y, Noda, K, Watanabe, K, Saijo, N
Wydane 2010

Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Onco...

od Tamura, K, Okamoto, I, Kashii, T, Negoro, S, Hirashima, T, Kudoh, S, Ichinose, Y, Ebi, N, Shibata, K, Nishimura, T, Katakami, N, Sawa, T, Shimizu, E, Fukuoka, J, Satoh, T, Fukuoka, M
Wydane 2008

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803)

od Yamamoto, N, Fukuoka, M, Negoro, S-I, Nakagawa, K, Saito, H, Matsui, K, Kawahara, M, Senba, H, Takada, Y, Kudoh, S, Nakano, T, Katakami, N, Sugiura, T, Hoso, T, Ariyoshi, Y
Wydane 2004

A randomized, open-label, multicenter, phase 3 study to compare the efficacy and safety of eribulin to treatment of physician’s choice in patients with advanced non-small cell lung...

od Katakami, N., Felip, E., Spigel, D. R., Kim, J.-H., Olivo, M., Guo, M., Nokihara, H., Yang, J. C.-H., Iannotti, N., Satouchi, M., Barlesi, F.
Wydane w Ann Oncol (2017)

A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial

od Kubota, K., Sakai, H., Katakami, N., Nishio, M., Inoue, A., Okamoto, H., Isobe, H., Kunitoh, H., Takiguchi, Y., Kobayashi, K., Nakamura, Y., Ohmatsu, H., Sugawara, S., Minato, K., Fukuda, M., Yokoyama, A., Takeuchi, M., Michimae, H., Gemma, A., Kudoh, S.
Wydane w Ann Oncol (2015)